5-nitrouracil has been researched along with Colorectal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aisu, N; Hasegawa, S; Hashimoto, Y; Kajitani, R; Kiyomi, F; Komono, A; Matsumoto, Y; Miyazaki, M; Munechika, T; Nagano, H; Sakamoto, R; Shimaoka, H; Yamada, T; Yoshida, Y; Yoshimatsu, G; Yoshimura, F | 1 |
1 other study(ies) available for 5-nitrouracil and Colorectal Neoplasms
| Article | Year |
|---|---|
5-Nitrouracil stabilizes the plasma concentration values of 5-FU in colorectal cancer patients receiving capecitabine.
Topics: Adult; Antimetabolites, Antineoplastic; Biotransformation; Capecitabine; Colorectal Neoplasms; Female; Fluorouracil; Humans; Liver; Male; Temperature; Thymidine Phosphorylase; Time Factors; Uracil | 2020 |